Osteoclasts in Paget's disease of bone
Pure red cell aplasia associated with small lymphocytic lymphoma
Woolf, the adversarial system and the concept of blame
CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (Apo-2L) in haematological malignancies
Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-hodgkin's lymphoma
Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor
Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2
Unusual T-cell receptor-δ gene rearrangement patterns revealed by screening of a large series of childhood acute lymphoblastic leukaemia by multiplex polymerase chain reaction
INK4A/ARF deletions are acquired at relapse in childhood acute lymphoblastic leukaemia: a paired study on 25 patients using real-time polymerase chain reaction
Hypermethylation of the calcitonin gene in acute lymphoblastic leukaemia is associated with unfavourable clinical outcome
Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide
The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sex
Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis
Fluorescence in situ hybridization analysis of 25 cases of idiopathic myelofibrosis and two cases of secondary myelofibrosis: monoallelic loss of RB1, D13S319 and D13S25 loci associated with cytogenetic deletion and translocation involving 13q14
Technetium-99m-sestamethoxyisobutylisonitrile scan as a predictor of chemotherapy response in malignant lymphomas compared with P-glycoprotein expression, multidrug resistance-related protein expression and other prognosis factors
A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303
bcl-2 expression in non-Hodgkin's lymphomas is not associated with bcl-2 gene rearrangements
Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemia
Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia
Anticipation in familial chronic lymphocytic leukaemia
Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma
Thalidomide in multiple myeloma: lack of response of soft-tissue plasmacytomas
Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma
Marked decrease in the Epstein-Barr virus positivity rate in nodular sclerosis subtype Hodgkin's disease in Tokyo: trend between 1955 and 1999
Diffuse large B-cell non-Hodgkin's lymphoma in a patient with autoimmune lymphoproliferative syndrome
Molecular cytogenetic characterization of an acquired minute supernumerary marker chromosome as the sole abnormality in a case clinically diagnosed as atypical Philadelphia-negative chronic myelogenous leukaemia
Variant Philadelphia translocations in chronic myeloid leukaemia can mimic typical blast crisis chromosome abnormalities or classic t(9;22): a report of two cases
Long-term outcome of patients surviving for more than ten years following treatment for acute leukaemia
Older patients with high-risk fungal infections can be successfully allografted using non-myeloablative conditioning in combination with intensified supportive care regimens
A pilot study of combined immunotherapy with autologous adoptive tumour-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2
A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest
Apoptosis and megakaryocytic differentiation during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin
Selective ex vivo expansion of cytomegalovirus-specific CD4+ and CD8+ T lymphocytes using dendritic cells pulsed with a human leucocyte antigen A*0201-restricted peptide
Immune neutropenia associated with anti-human neutrophil antigen-2a (NB1) antibodies following unrelated donor stem cell transplantation for chronic myeloid leukaemia: perpetuation by granulocyte colony-stimulating factor
Oxidative stress and erythrocyte damage in Kenyan children with severe Plasmodium falciparum malaria
Growth of Plasmodium falciparum induces stage-dependent haemichrome formation, oxidative aggregation of band 3, membrane deposition of complement and antibodies, and phagocytosis of parasitized erythrocytes
Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation
A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome
Platelet tests in the prediction of myocardial infarction and ischaemic stroke: evidence from the Caerphilly Prospective Study
Endothelial cell prostacyclin synthesis induced by lymphocytes is independent of the membrane fatty acid composition of both cell types and of E-selectin, VCAM-1 or ICAM-1-mediated adhesion
Potency estimation of recombinant factor VIII: effect of assay method and standard
Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis
Anti-prothrombin antibodies: assay conditions and clinical associations in the anti-phospholipid syndrome
Antibodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome
The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden
Incidence and associations of acute renal failure complicating high-dose intravenous immunoglobulin therapy
Following the course of malaria treatment by detecting parasite lactate dehydrogenase enzyme
Thrombolysis failure: a role for plasminogen activator inhibitor type 1 (PAI‐1)
Potential strategies for the treatment of plasma exchange-resistant thrombotic thrombocytopenic purpura
Reply to Quintini et al